Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TALTZ safely and effectively. See full prescribing information for TALTZ.TALTZ (ixekizumab) injection, for subcutaneous useInitial U.S. Approval: 2016
Medication labelWhy this: Advisory · dailymed-prescription
TALTZ® is indicated for the treatment of patients 6 years of age and older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. TALTZ is indicated for the treatment of adult patients with active psoriatic arthritis. TALTZ is indicated for the treatment of adult patients with active ankylosing spondylitis. TALTZ is indicated for the treatment of adult patients with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation.
- generic_name
- ixekizumab
- product_names
- ixekizumab
- ndc
- 0002-1445, 0002-1445-01, 0002-1445-11, 0002-1445-27, 0002-1445-09, 0002-1445-61, 0002-7724, 0002-7724-01, 0002-7724-11, 0002-7724-99, 0002-8900, 0002-8900-01, 0002-8900-11, 0002-8905, 0002-8905-01, 0002-8905-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en